Menopause telehealth: HRT, the honest version
The narrative on hormone replacement therapy (HRT) has shifted 180 degrees since the early 2000s. For most women in perimenopause and the first 10 years of post-menopause, HRT benefits outweigh risks. Telehealth has made it dramatically more accessible than the prior in-person-only model.
Jump to section
What HRT actually does
Estrogen treats vasomotor symptoms (hot flashes, night sweats), genitourinary symptoms (vaginal dryness, painful sex, urinary urgency), and protects bone density. Progesterone is added if you have a uterus (to protect the lining from estrogen). Testosterone, prescribed off-label, may help libido but evidence is weaker.
Delivery methods
Transdermal estrogen (patches, gels, sprays) has the best safety profile — bypasses the liver, lower clot risk than oral estrogen. Oral estradiol is cheaper. Vaginal estrogen (creams, tablets, rings) for genitourinary symptoms alone is very low-dose and very low-risk, even for women with breast cancer history (with oncologist approval).
When to start and stop
Start around symptom onset, typically perimenopause through age 60. Continue as long as symptoms persist and benefits outweigh risks. There is no hard age cutoff — individualized decision. Women starting HRT in their 70s for the first time have a different risk profile than women continuing it from age 50.
What telehealth handles vs not
Routine HRT initiation, dose adjustment, side-effect management, and renewals: telehealth-appropriate. Initial workup if you have personal or family history of breast/ovarian cancer, clotting disorders, or stroke: in-person consultation first. Costs: compounded HRT $50-150/month, branded patches $90-200/month.